Tempus AI Operating Income 2023-2025 | TEM
Tempus AI annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Tempus AI operating income for the quarter ending June 30, 2025 was $-0.062B, a 88.42% decline year-over-year.
- Tempus AI operating income for the twelve months ending June 30, 2025 was $-0.235B, a 64.46% decline year-over-year.
- Tempus AI annual operating income for 2024 was $-0.691B, a 252.44% increase from 2023.
- Tempus AI annual operating income for 2023 was $-0.196B, a 26.13% decline from 2022.
- Tempus AI annual operating income for 2022 was $-0.265B, a 0% decline from .
|
Tempus AI Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-691 |
| 2023 | $-196 |
| 2022 | $-265 |
|
Tempus AI Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-62 |
| 2025-03-31 | $-69 |
| 2024-12-31 | $-51 |
| 2024-09-30 | $-54 |
| 2024-06-30 | $-533 |
| 2024-03-31 | $-53 |
| 2023-12-31 | $-29 |
| 2023-09-30 | $-45 |
| 2023-06-30 | $-45 |
| 2023-03-31 | $-54 |
| 2022-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.470B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.476B | 59.15 |
| Doximity (DOCS) | United States | $9.841B | 40.73 |
| Hims & Hers Health (HIMS) | United States | $9.345B | 76.02 |
| IRhythm Technologies (IRTC) | United States | $5.680B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Heartflow (HTFL) | United States | $2.821B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 41.38 |
| 10x Genomics (TXG) | United States | $2.126B | 0.00 |
| Enovis (ENOV) | United States | $1.731B | 9.09 |
| Omnicell (OMCL) | United States | $1.652B | 33.77 |
| Azenta (AZTA) | United States | $1.387B | 60.52 |
| Phreesia (PHR) | United States | $1.355B | 0.00 |
| Schrodinger (SDGR) | United States | $1.346B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Claritev (CTEV) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.840B | 0.00 |
| Evolent Health (EVH) | United States | $0.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.560B | 112.67 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Standard BioTools (LAB) | United States | $0.450B | 0.00 |
| Carlsmed (CARL) | United States | $0.335B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.294B | 0.00 |
| TruBridge (TBRG) | United States | $0.286B | 13.15 |
| CapsoVision (CV) | United States | $0.231B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.201B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.195B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
| CareCloud (CCLD) | United States | $0.143B | 7.84 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.025B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.000B | 0.00 |